Pharma Tips

Merck & Co and Pfizer Join Forces on Diabetes Pill

By: Pharma News | Views: 1312 | Date: 02-May-2013

Drug giants Merck & Co and Pfizer have formed a new alliance to jointly develop and commercialize the latter's ertugliflozin for the treatment of type II diabetes.

Merck & Co and Pfizer Join Forces on Diabetes Pill

Drug giants Merck & Co and Pfizer have formed a new alliance to jointly develop and commercialize the latter's ertugliflozin for the treatment of type II diabetes.

 

Merck & Pfizer

 

The drug is an investigational oral sodium glucose cotransporter (SGLT2) inhibitor, which is on the verge of entering Phase III trials, scheduled for later this year.

 

Under the terms of the global (except Japan) collaboration agreement, the firms will work together on the clinical development of ertugliflozin, as well as combinations of the drug with Merck's diabetes pill Januvia (sitagliptin) and metformin.

 

Merck has already handed over $60 million in upfront fees and milestones, but Pfizer also stands to receive additional payments linked to preset future clinical, regulatory and commercial milestones.

 

The companies said they will share any revenues and some costs on a 60/40% basis.

“Through this collaboration, we believe we can build on Merck’s leadership position in diabetes care with the introduction of ertugliflozin, an innovative SGLT2 inhibitor discovered by Pfizer scientists,” noted John Young, president and general manager, Pfizer Primary Care.

 


Previous Page Next Page

People Searching On This Page:
  • new pharma company in diabetes
  • quality control
  • quality

Related Pages


Pfizer has signed a deal with a French biotech company Cellectis

Pfizer has signed a deal with a French biotech company Cellectis

News | Pharma Companies
Date:
22-Apr-2015  Views: 721

Pfizer Inc. (PFE) has a signed a deal with French biotech company, Cellectis, to develop cancer immunotherapies. Under the agreement, Cellectis will d ...
Novartis announces a joint investment company with Qualcomm

Novartis announces a joint investment company with Qualcomm

News | Pharma Companies
Date:
29-Jan-2015  Views: 1295

Novartis Pharmaceuticals has announced the establishment of a joint investment company with Qualcomm Ventures to target early stage companies who offe ...
B.Pharm, M.Pharm as Data Analyst Pharmacovigilance Jobs in Cognizant

B.Pharm, M.Pharm as Data Analyst Pharmacovigilance Jobs in Cognizant

Jobs | Pharmacovigilance | Mumbai
Date:
13-May-2014  Views: 5284

Cognizant is a leading provider of information technology, consulting, and business process outsourcing services, dedicated to helping the world's lea ...
GMP Control of Components and Drug Product Containers and Closures (SUBPART E)

GMP Control of Components and Drug Product Containers and Closures (SUBPART E)

Articles | Quality Assurance | GMP
Date:
24-Apr-2011  Views: 3080

(a) There shall be written procedures describing in sufficient detail the receipt, identification, storage, handling, sampling, testing and approva ...
Beacon is looking for Oncology Consultant in Production and Quality Control | Bangladesh

Beacon is looking for Oncology Consultant in Production and Quality Control | Bangladesh

Jobs
Date:
18-Jul-2010  Views: 1710

Beacon is looking for Oncology Consultant who will be able to manage production and Quality Control (QC) protocol of Oncology Products. ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

68  + 2 =     
Comments
People Searched About:
New Pharma Company In Diabetes   |   Quality Control   |   Quality   |  
Google : 122 times | Yahoo : 14 times | Bing : 20 times |